CHOP

Aug 21, 2019

New Fund to Assist Patients Living with Mantle Cell Lymphoma Opens at the HealthWell Foundation

Aug 11, 2019

A New Model for Lymphoma Drug Discovery

Jun 15, 2018

European Hematology Association: AHL2011: Outstanding Disease Control With a Minimized BEACOPP Exposure and Toxicity in Patients With Advanced Hodgkin Lymphoma

Jun 11, 2018

Nordic Nanovector to Present Preclinical Data Demonstrating Betalutin® Reverses Resistance to Anti-CD20 Treatment in NHL Cells

Apr 03, 2018

First Patient Dosed In Pivotal Biomarker-Guided Phase 3 Study Of First Line Therapy With DB102 (enzastaurin) + R-CHOP In Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)

Dec 07, 2017

Bayer to Highlight New Research at ASH 2017

Dec 07, 2017

Bayer to Highlight New Research at ASH 2017

Oct 22, 2017

Formerly Conjoined Twins, Erin and Abby Delaney, Thriving Months After Separation Surgery at Children's Hospital of Philadelphia

Jun 24, 2017

European Hematology Association: Early Metabolic Response Determination by FDG-PET Allows Substantial Reduction of Chemotherapy and its Toxicity in Patients with Advanced Stage Hodgkin Lymphoma: the GHSG HD18 Study

Jun 19, 2017

Enzychem Lifesciences Announces Initiation of Global Phase 2 Trial of EC-18 in Patients with Chemotherapy Induced Neutropenia(CIN)